Rankings
▼
Calendar
XENE Q3 2020 Earnings — Xenon Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena
XENE
Xenon Pharmaceuticals Inc.
$5B
Q3 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$7M
+87.3% YoY
Gross Profit
$7M
100.0% margin
Operating Income
-$10M
-148.0% margin
Net Income
-$9M
-135.1% margin
EPS (Diluted)
$-0.25
QoQ Revenue Growth
-51.0%
Cash Flow
Operating Cash Flow
-$12M
Free Cash Flow
-$13M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$199M
Total Liabilities
$17M
Stockholders' Equity
$182M
Cash & Equivalents
$15M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$7M
$4M
+87.3%
Gross Profit
$7M
-$6M
+204.8%
Operating Income
-$10M
-$9M
-8.4%
Net Income
-$9M
-$9M
+0.2%
Revenue Segments
License And Service
$7M
100%
← FY 2020
All Quarters
Q4 2020 →